FY2024 EPS Estimates for DENTSPLY SIRONA Inc. Lowered by Analyst (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities research analysts at Leerink Partnrs reduced their FY2024 earnings estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Thursday, May 2nd. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will earn $2.01 per share for the year, down from their previous forecast of $2.06. Leerink Partnrs has a “Outperform” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.04 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2025 earnings at $2.40 EPS, FY2026 earnings at $2.75 EPS and FY2027 earnings at $3.07 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same quarter last year, the firm earned $0.39 EPS. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year.

A number of other analysts have also weighed in on XRAY. Barrington Research dropped their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Piper Sandler reissued a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. The Goldman Sachs Group dropped their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday. Finally, SVB Leerink assumed coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price for the company. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $35.22.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $28.25 on Monday. The business has a 50-day moving average of $31.91 and a 200 day moving average of $32.66. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA has a 1-year low of $26.27 and a 1-year high of $41.65. The stock has a market capitalization of $5.87 billion, a PE ratio of -64.20, a P/E/G ratio of 1.24 and a beta of 1.00.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently modified their holdings of the stock. Norges Bank purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth about $114,207,000. Nuance Investments LLC increased its stake in DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock worth $412,982,000 after acquiring an additional 2,702,457 shares during the last quarter. Generation Investment Management LLP lifted its stake in shares of DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after purchasing an additional 1,998,012 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after purchasing an additional 1,419,503 shares during the period. Finally, SG Americas Securities LLC raised its holdings in DENTSPLY SIRONA by 2,959.1% during the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock valued at $45,584,000 after buying an additional 1,328,525 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.